A new drug has received a quick federal nod for adults with a serious kidney disorder known as primary immunoglobulin A nephropathy (IgAN). The drug is […]

Nearly a year after performing the first transplant of a pig kidney into a living human recipient, Massachusetts General Hospital (MGH), Boston, reported that a second […]

With efforts underway to expand access to the kidney transplant waiting list to more patients, including many with end-stage kidney disease (ESKD), new research underscored the […]

March 21, 2025 — The FDA has approved a drug as the first and only treatment for adults with C3 glomerulopathy (C3G) to reduce protein in […]

Chronic kidney disease (CKD) can cause dysfunction in organs well outside the renal system. The skin is one of the organs most commonly affected. CKD is […]

World Kidney Day, observed every second Thursday of March since 2006, promotes access to health education, healthcare, and kidney disease prevention. A key breakthrough in this […]

Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) inhibitors as first-line therapy, and personalized treatment approaches for kidney and cardiovascular risk reduction […]